Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/12/20
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 04/30/15
End: 10/31/15
Due: 10/31/16
Phase: N/A
Priority: Normal
Start: 02/27/17
End: 04/27/18
Due: 04/27/19
Phase: N/A
Priority: Normal
Start: 10/24/17
End: 09/18/18
Due: 09/18/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Topical 2% Povidone-Iodine Gel in Verruca Vulgaris | NCT04253912 | Veloce BioPharma LLC | user2@example.com | None | 2020-02-12 | 2021-04-30 | 2022-04-30 | - | - | 2025-07-14 |
| ALC-919 For The Treatment Of Common Warts | NCT02483455 | Veloce BioPharma LLC | user2@example.com | None | 2015-04-30 | 2015-10-31 | 2016-10-31 | - | - | 2025-07-14 |
| A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum | NCT03077750 | Veloce BioPharma LLC | user2@example.com | None | 2017-02-27 | 2018-04-27 | 2019-04-27 | - | - | 2025-07-14 |
| A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients | NCT03207906 | Veloce BioPharma LLC | user2@example.com | None | 2017-10-24 | 2018-09-18 | 2019-09-18 | - | - | 2025-07-14 |